Henning Weigt

Statistics

Publications

Citations

598

H-Index

Active since

2003

Affiliations

Fraunhofer Institute for Toxicology and Experimental Medicine(Current)

Medizinische Hochschule Hannover

Henning Weigt is an author at Fraunhofer Institute for Toxicology and Experimental Medicine specializing in immunology, life sciences, and pharmacology.

ORCID

Publications per year

2003–2020

Publications

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

Jörg Täubel, Wilfried Hauke, Steffen Rump et al. · European Heart Journal · 2020 · 376 citations · Full text

Medicine, Cardiology, Pharmacology +17

Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells

Henning Weigt, Peter F. Mühlradt, Andreas Emmendörffer et al. · Immunobiology · 2003 · 63 citations

Life Sciences, Biochemistry, Immunology +11

The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP

Sophie E. B. Ambjørner, Michael Wiese, Sebastian C. Köhler et al. · Cells · 2020 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

The Toll-Like Receptor-2/6 Agonist Macrophage-Activating Lipopeptide-2 Cooperates with IFN-γ to Reverse the Th2 Skew in an In Vitro Allergy Model

Henning Weigt, Peter F. Mühlradt, Michael Larbig et al. · The Journal of Immunology · 2004 · 34 citations · Full text

Life Sciences, Immunology, Allergy +16

Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis

Wolfgang Bäumer, Boris Sülzle, Henning Weigt et al. · British Journal of Dermatology · 2005 · 33 citations

Medicine, Immunology, Pharmacology +17

1–5 of 7